CHARLESTON, S.C. — When Web page Campbell’s physician really helpful she strive an injectable prescription drug referred to as Wegovy to drop extra pounds earlier than scheduling bariatric surgical procedure, she readily agreed.
“I’ve struggled with my weight for thus lengthy,” stated Campbell, 40, a single mom of two. “I’m not against attempting something.”
In early April, about 4 weeks after she’d began taking Wegovy, Campbell stated she hadn’t skilled any uncomfortable side effects, reminiscent of nausea or bowel irritation. However she doesn’t use a scale at residence, she stated, so she didn’t know whether or not she’d misplaced any weight since her most up-to-date medical appointment earlier this yr, when she weighed 314 kilos. Nonetheless, she was assured about attaining weight reduction.
“It’s going to work as a result of I’m placing within the work. I’m altering my consuming habits. I’m exercising,” stated Campbell, a transport supervisor at a Michaels retailer. “I’m not going to second-guess myself.”
Wegovy belongs to an expensive class of medicine referred to as GLP-1s (quick for glucagon-like peptide-1 agonists) which have upended the remedy of weight problems in recent times, providing hope to sufferers who’ve tried and did not drop extra pounds in myriad different methods.
Campbell gained entry to Wegovy by way of South Carolina Medicaid’s determination in late 2024 to cowl these weight reduction medicine. However the medicines stay out of attain for tens of millions of sufferers throughout the nation who may gain advantage from them, as a result of many private and non-private well being insurers have deemed the medicine too costly.
A report printed in November by KFF, a well being info nonprofit that features KFF Well being Information, discovered solely 13 states had been protecting GLP-1s for the remedy of weight problems for Medicaid beneficiaries as of August. South Carolina turned the 14th in November.
Liz Williams, one of many report’s authors and a senior coverage supervisor for the Program on Medicaid and the Uninsured at KFF, stated she was not conscious of some other state Medicaid packages becoming a member of the record since then. Wanting forward, the remaining states could also be reluctant so as to add a brand new, costly drug profit whereas they brace for potential federal cuts coming from Congress, she stated.
“Because the funds debate, federally, is growing, that will influence how states are fascinated by this,” Williams stated.
The federal authorities received’t be serving to anytime quickly, both. Medicare covers GLP-1s to deal with diabetes and another well being circumstances, together with obstructive sleep apnea and heart problems, however not weight problems. In early April, the Trump administration introduced it is not going to finalize a rule proposed by the Biden administration that might have allowed an estimated 7.4 million individuals lined by Medicare and Medicaid to entry GLP-1s for weight reduction. In the meantime, the FDA is poised to drive inexpensive, compounded variations of those medicine off the market.
And the barrier to entry stays excessive, even for Medicaid sufferers in these few states which have agreed to cowl the medicine and not using a federal mandate.
Living proof: In South Carolina, the place greater than one-third of all adults, and almost half of the African American inhabitants, qualify as overweight, the state Medicaid company estimates just one,300 beneficiaries will meet the stringent stipulations for GLP-1 protection.
Beneath a type of necessities, Medicaid beneficiaries who want to entry these medicine to drop extra pounds should attest to “elevated train exercise,” stated Jeff Leieritz, a spokesperson for the South Carolina Division of Well being and Human Companies.
Campbell, who’s insured by Medicaid, was granted protection for Wegovy primarily based on her physique mass index. First, although, she was required to submit six months’ price of documentation proving that she’d tried and did not drop extra pounds after receiving vitamin counseling and happening a 1,200-calorie-a day weight loss program, stated Kenneth Mitchell, one in every of Campbell’s medical doctors and the medical director for bariatric surgical procedure and weight problems medication at Roper St. Francis Healthcare.
Campbell’s Wegovy prescription was accredited for six months, Mitchell stated. When that authorization expires, Campbell and her well being care workforce might want to submit extra documentation, together with proof that she has misplaced no less than 5% of her physique weight and has stored up with vitamin counseling.
“It’s not simply, ‘Ship a prescription in and so they cowl it.’ It’s relatively arduous,” Mitchell stated. “Not plenty of of us are going to do that.”
Mitchell stated South Carolina Medicaid’s determination to cowl these medicine was met with pleasure amongst these working in his medical specialty. However he wasn’t stunned that the state anticipates comparatively few individuals will entry this profit yearly, for the reason that approval course of is so rigorous and the price excessive. “The issue is the medicines are so costly,” Mitchell stated.
Novo Nordisk, which manufactures Wegovy, introduced in March that it was reducing the month-to-month value for the drug from $650 to $499 for cash-paying clients. The value that medical health insurance plans and beneficiaries pay for these medicine varies, however some GLP-1s price greater than $1,000 per affected person per 30 days, Mitchell stated, and many individuals might want to take them for the remainder of their lives to keep up weight reduction.
“That may be a great price ticket that somebody has to foot the invoice for,” Mitchell stated.
That’s the explanation California Gov. Gavin Newsom on Could 14 proposed eliminating Medicaid protection of GLP-1s for weight reduction beginning Jan. 1, to save lots of an estimated $680 million a yr by 2028.
And the North Carolina State Well being Plan Board of Trustees voted final yr to finish protection of GLP-1s for state staff, after then-North Carolina Treasurer Dale Folwell’s workplace estimated in 2023 that the medicine had been projected to price the State Well being Plan $1 billion over the following six years. The choice got here only some months after a separate North Carolina company introduced it might begin protecting these medicine for Medicaid beneficiaries. North Carolina Medicaid has estimated it’s going to spend $16 million a yr on GLP-1s.
South Carolina Medicaid, which insures fewer than half the variety of individuals enrolled in North Carolina Medicaid, anticipates spending much less. Leieritz estimated GLP-1s and vitamin counseling provided to Medicaid beneficiaries in South Carolina will price $10 million a yr. State funding will cowl $3.3 million of the expense; the rest will probably be paid for by matching Medicaid funds from the federal authorities.
In a current interview, Well being and Human Companies Secretary Robert F. Kennedy Jr. didn’t rule out the likelihood that Medicare and Medicaid would possibly cowl GLP-1s for weight problems remedy sooner or later as prices come down.
They’re “extraordinary medicine” and “we’re going to scale back the price,” Kennedy advised CBS Information in early April. He stated he would really like GLP-1s to finally be made accessible to Medicare and Medicaid sufferers who’re in search of weight problems remedy after they’ve tried different methods to drop extra pounds. “That’s the framework that we’re now debating.”
In the meantime, public well being specialists have applauded South Carolina Medicaid’s determination to cowl GLP-1s. But the brand new profit received’t assist the overwhelming majority of the 1.5 million adults in South Carolina who’re labeled as overweight, in response to information printed by the South Carolina Division of Public Well being.
“We nonetheless have some work to do,” acknowledged Brannon Traxler, the general public well being division’s chief medical officer.
However the state’s new “Motion Plan for Wholesome Consuming and Lively Residing,” written by a coalition of teams in South Carolina, together with the Division of Public Well being, makes no point out of GLP-1s or the position they could play in decreasing weight problems charges within the state.
The motion plan, underwritten by a $1.5 million federal grant, isn’t meant to put out an overarching method for decreasing weight problems in South Carolina, Traxler stated. As a substitute, it promotes bodily exercise in faculties, vitamin, and the growth of outside strolling trails, amongst different methods. A extra complete weight problems plan would possibly tackle the advantages of surgical intervention and GLP-1s, however these additionally carry danger, expense, and uncomfortable side effects, Traxler stated.
“Definitely, I believe, there’s a must convey all of it collectively,” she stated.
Campbell, for one, is taking the great method. On high of injecting Wegovy as soon as weekly, she stated, she is prioritizing protein consumption and transferring her physique. She additionally underwent weight reduction surgical procedure in late April.
“Weight reduction is my greatest objective,” stated Campbell, who expressed appreciation for Medicaid’s protection of Wegovy. “It’s yet one more factor that’s going to assist me get to my objective.”
